Last updated: August 29, 2023
Sponsor: Chinese SLE Treatment And Research Group
Overall Status: Completed
Phase
N/A
Condition
Joint Injuries
Bone Diseases
Rheumatoid Arthritis
Treatment
TSQM-II
Clinical Study ID
NCT03483597
CRDC-satisfaction
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Doctors - registered rheumatoid specialist physicians subordinated to the 12 designatedhospitals Patients - aged over 18, confirming RA for more than 6 months
Exclusion
Exclusion Criteria: Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to completethe questionnaire independently), without any RA treatment
Study Design
Total Participants: 1365
Treatment Group(s): 1
Primary Treatment: TSQM-II
Phase:
Study Start date:
March 31, 2018
Estimated Completion Date:
April 30, 2018
Study Description
Connect with a study center
Peking Union Medical College Hospital
Beijing, 100730
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.